Prognosis of synchronous endometrial and ovarian cancer based on the PROMISE molecular system.

Wang M, Li Y, Xu J, Xu S, Wu Y
Chinese medical journal · 2024 · doi:10.1097/cm9.0000000000003062 · PMID:38867410 · PMC12077555
OA: gold CC-BY-NC-ND-4.0
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-21 ⓘ

This study evaluated the prognostic capabilities of the PROMISE molecular system for synchronous endometrial and ovarian cancers.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-08-23T09:30:01.253652+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-NC-ND-4.0